GRDN Guardian Pharmacy Services, Inc.

Overview and Growth

In fiscal 2025, Guardian Pharmacy Services, Inc. recorded $1.45B of revenue, net income of $49.22M, and an operating cash inflow of $100.25M. The $1.45B revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Compared with $1.23B in fiscal 2024, revenue recorded a 17.9% year-over-year increase. Asset turnover was 3.51x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

Gross profit was $292.72M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross margin was 20.2%, so that share of each revenue unit remained after the cost of revenue reported for the period. The reported operating result was $72.70M, capturing profitability after direct costs and the operating expenses reflected in the statements. Relative to revenue, operating income represented 5.0%, showing how efficiently sales converted into operating profit. After all reported below-operating-line items, the company recorded net income of $49.22M for the fiscal year. Measured against reported revenue, net income produced a 3.4% margin after operating costs and the remaining recognized items. The earnings statement records $73.42M of pretax income, the profit base against which the reported tax provision can be assessed. Measured against revenue, pretax income equaled 5.1%, adding a pre-tax profitability layer between revenue and net income. The company recognized $24.46M of income tax for the period, completing the transition from pretax income to net income. The effective relationship between income tax and positive pretax income was 33.3%, without assuming a statutory-rate comparison. Net income equaled 22.6% of period-end equity, showing the earnings generated on shareholders’ book capital. Return on period-end assets was 11.9%, connecting net income with the company’s total asset base.

Liquidity and Capital Structure

At period end, the $412.66M asset base was financed through $194.73M of liabilities and $217.92M of equity. Current assets were $221.63M against $160.70M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. The current ratio was 1.38x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Cash and equivalents totaled $65.62M, identifying the most liquid reported component available within the broader current-asset balance. The cash balance equaled 40.8% of current liabilities, showing how much near-term coverage came from cash alone. Total debt was $0.00, establishing the amount of borrowing carried within the company’s capital structure. Debt equaled 0.0x of book equity, describing the relative scale of borrowing and shareholder capital. The debt-to-assets relationship was 0.0%, comparing borrowing with the total asset balance. The liabilities-to-assets relationship was 47.2%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 15.9%, a balance-sheet composition measure rather than a liquidity forecast. The asset base changed 28.6% from $320.81M in fiscal 2024, leaving current total assets higher year over year.

Cash Flow and Earnings Quality

The company reported $100.25M of operating cash flow, a cash inflow that shows the cash generated by operations. Operating cash flow equaled 2.04x of net income, showing how strongly accounting earnings converted into cash from operations. Capital expenditures used $13.42M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Relative to operating cash flow, capital expenditures measured 13.4%, connecting investment intensity with the company’s cash-generation base. After capital spending, free cash flow was $86.84M, leaving cash available for debt reduction, shareholder returns, or further investment. The free-cash-flow margin was 6.0%, measuring cash remaining after capital spending against revenue. Measured against total assets, free cash flow represented 21.0%, showing the cash productivity of the company’s assets.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.